Shapouri-Moghaddam Abbas, Mohammadi Mojgan, Rahimi Hamid Reza, Esmaeili Habibolah, Mahmoudi Mahmoud, Saeed Modaghegh Mohammad-Hadi, Tavakol Afshari Jalil
Immunology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Allergy Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Rep Biochem Mol Biol. 2019 Jul;8(2):153-160.
Thromboangiitis obliterans (TAO), also known as Burger's disease, is a devastating disease affecting the arteries and veins of the upper and lower distal limbs most commonly afflicting young male smokers of low socioeconomic status. The expression of human leukocyte antigen (HLA)-A, B and -DRB1 genes have been implicated in the pathogenesis of TAO. Our study aimed to examine the association of different HLA-A, B and -DRB1 genes in TAO patients in the Iranian population.
A case-control study examining 55 Iranian patients with TAO and 500 healthy subjects was performed in Imam Reza hospital, Mashhad, Iran. The prevalence of major histocompatibility complex (MHC) class I (-A, -B) and class II (-DRB) alleles were determined for each participant.
Our results revealed the -A03 (odds ratio [OR]=5.394), -A24 (OR=5.143), -A31 (OR=4.251), -A11 (OR=3.034), HLA-B27 (OR=6.680), HLA-B15 (OR=3.959), -B07 (OR=3.698), -B51 (OR=3.370), -B44 (OR=3.326), -DRB116 (OR=20.583), HLADRB1* 04 (OR=8.960), -DRB114 (OR=3.746), -DRB103 (OR=2.303), and -DRB115 (OR=2.111) alleles to occur at a significantly higher frequency in TAO patients compared to controls (p<0.05). The -A25, -A66, -DRB108, -DRB110, and -DRB112 alleles resulted in infinite OR, and was associated with an increased risk of TAO. However, the alleles -A30, -B08, -B45, -B46, and -B*53 were associated with a protective role against TAO with an OR = 0.
This is the first study examining the pattern in patients with Burger's disease in the Iranian population. Our findings have revealed an association between class I and II alleles with TAO.
血栓闭塞性脉管炎(TAO),又称伯格氏病,是一种严重疾病,主要影响上下肢远端的动静脉,最常折磨社会经济地位较低的年轻男性吸烟者。人类白细胞抗原(HLA)-A、B和-DRB1基因的表达与TAO的发病机制有关。我们的研究旨在探讨伊朗人群中TAO患者不同HLA-A、B和-DRB1基因之间的关联。
在伊朗马什哈德的伊玛目礼萨医院进行了一项病例对照研究,研究对象为55例伊朗TAO患者和500名健康受试者。测定了每个参与者主要组织相容性复合体(MHC)I类(-A、-B)和II类(-DRB)等位基因的流行率。
我们的结果显示,与对照组相比,TAO患者中-A03(优势比[OR]=5.394)、-A24(OR=5.143)、-A31(OR=4.251)、-A11(OR=3.034)、HLA-B27(OR=6.680)、HLA-B15(OR=3.959)、-B07(OR=3.698)、-B51(OR=3.370)、-B44(OR=3.326)、-DRB116(OR=20.583)、HLA-DRB104(OR=8.960)、-DRB114(OR=3.746)、-DRB103(OR=2.303)和-DRB115(OR=2.111)等位基因的出现频率显著更高(p<0.05)。-A25、-A66、-DRB108、-DRB110和-DRB112等位基因导致无限OR,并与TAO风险增加相关。然而等位基因-A30、-B08、-B45、-B46和-B53与预防TAO的作用相关,OR=0。
这是第一项研究伊朗人群中伯格氏病患者模式的研究。我们的研究结果揭示了I类和II类等位基因与TAO之间的关联。